Transcript research - UCLA Integrated Substance Abuse Programs

Promoting Diversity and Science
for Health Equity
-- Introduction of NIDA
Minority Diversity Programs
Yu (Woody) Lin, M.D., Ph.D
Program Director
Division of Clinical Neuroscience
and Behavior Research
National Institute on Drug Abuse/NIH
NIH Mission
NIH is the steward of medical and behavioral
research for the Nation
Our mission: to acquire new knowledge to help
prevent, detect, diagnose, and treat disease and
disability …
• Support research by non-Federal scientists across
U.S. and abroad
• Help train research investigators
• Foster communication of medical and health
sciences information
Total NIH Budget Authority – FY 2011
$32.23 Billion
Research Project
Grants 53%
$16.42 Billion
Training 2% $722 Million
NIDA’s Mission
Bring the power of science to bear research
on drug abuse and addiction
- Support and conduct cross-disciplinary
research to better understand, treat
and prevent drug abuse and addiction
- Disseminate research results to improve
prevention, treatment, and policy
From Molecules…
NIDA BUDGET
(Thousands)
2011
2012
2013
PB
NonAIDS
$731,428
$732,822
$732,838
AIDS
$317,348
$319,292
$321,163
$1,048,776
$1,052,114
$1,054,001
0.3%
0.2%
TOTAL
Increase
Over
Prior Year
-1.0%
National Institute on Drug Abuse Portfolio
FY 2010 Actual
Basic & Clinical Neuroscience &
Behavioral Research -- 46%
Epidemiology, Services &
Prevention Research -- 23%
Pharmacotherapies &
Medical Consequences -- 12%
Clinical Trials Network -- 4%
Intramural Research -- 8%
RM&S -- 6%
National Institute on Drug Abuse
Office of the Director
Nora D. Volkow, MD
Director
David Shurtleff, PhD
Acting Deputy Director
Glenda Conroy
Executive Officer
Special Populations Office
David Shurtleff, PhD
Gender Research
Cora Lee Wetherington, PhD
Office of Extramural
Affairs
Teresa Levitin, PhD
Division of Basic
Neuroscience &
Behavioral Research
Joni Rutter, PhD
HIV/AIDS Research
Jacques Normand, PhD
International Program
Steve Gust, PhD
Office of Planning &
Resource
Management
Office of
Science Policy &
Communications
Center for the
Clinical Trials
Network
Helio Chaves
Susan Weiss, PhD
Betty Tai, PhD
Division of
Pharmacotherapies &
Medical Consequences
of Drug Abuse
David McCann, PhD
Division of
Epidemiology, Services
& Prevention Research
Wilson Compton,
MD, MPE
Division of Clinical
Neuroscience &
Behavioral Research
Intramural
Research Program
Anto Bonci, MD
Joseph Frascella, PhD
Special Populations Office (SPO)
National Institutes of Health
• Increase diverse workforce & activity
• Promote science for health equity
Special Populations Office (SPO)
What We Do:
The NIDA Special Populations Office (SPO) aims are to:
(1) increase the number of underrepresented scholars and researchers
actively participating in drug abuse research through our outreach,
and sponsored career development and research training programs
(2) ensure that minority/health disparity issues and research are
adequately and appropriately represented in NIDA’s extramural
research programs as described in NIDA’s strategic plan in
addressing health disparities.
Special Populations Office (SPO)
The NIDA SPO coordinates the Institute’s diversity-directed
research, concentrating on areas where there are significant gaps
in knowledge and/or clear Disparities in prevention and treatment.
SPO DIRECTOR
SPO STAFF
AAPI RS
Workgroup
NA/AN RS
Workgroup
AA RS
Workgroup
NIDA Diversity Research Program
NHSN
Workgroup
Researchers & Scholars Workgroups
Each Work Group is currently comprised of established
researchers and scholars with expertise in drug abuse and
addiction research and health concerns of the particular
population it represents.
1.Provide guidance and recommendations to NIDA:
• Drug abuse and addiction research development
• Training needs within 4 major diverse populations
2.Identify concerns, and stimulate research on drug
abuse/addiction associated with particular
population it represents.
American Indian/
Alaska Native
Work Group
African American
Work Group
SPO Research & Training Programs
Promoting Diversity and Science
for Health Equity
 Diversity -promoting Institutions Drug
Abuse Research Program (DIDARP)
 Diversity Supplements
 Research Development Seminar Series
 Summer Research with NIDA
NIDA Diversity-Promoting Institutions Drug
Abuse Research Program (DIDARP)
The overall goal of the DIDARP is the capacity development of the
applicant institution to support drug abuse research through the
following objectives:
(1) Provide faculty with drug abuse research knowledge and skill development through
the conduct of research projects and other professional development activities;
(2) Encourage students from disadvantaged backgrounds to pursue drug abuse research
careers by providing them with educational enrichment and research experiences;
(3) Strengthen the underlying institutional infrastructure needed to support drug abuse
research.
(4) Budgets up to $350,000 (direct costs/year (5 years); NIDA review, division fund
http://grants.nih.gov/grants/guide/pa-files/PAR-11-060.html
NIDA Diversity-Promoting Institutions Drug
Abuse Research Program (DIDARP)
Since 2005, NIDA has supported 15 DIDARPs. There
are 11 active DIDARP projects; including these 7
institutions that have not been previously supported:
• University of Houston
• Howard University
• Meharry Medical College
• Morehouse School of Medicine
• University of Puerto Rico School of Public Health
• California State University – San Bernandino
• University of Hawaii
• NIDA Program Contact: Pamela Goodlow
Diversity Supplements Program
• Supplements certain active (> 1 year) research grants
• Provides mentoring/training for an identified individual
from an underrepresented or disadvantaged population:
* Racial/Ethnic Minority
* Investigator who becomes disabled
* Individual with disability
* Disadvantaged Background
• Supports persons at five levels:
* High school
* Undergraduates
* Graduate students * Post doctoral
* Investigators
• NIDA internal review; a NIH-wide program
• Type/Amount of support varies with levels
NIDA Program Contact: Pamela Goodlow
15
NIDA Diversity Supplement Awards
FY
FY 1994
FY 1995
FY 1996
FY 1997
FY 1998
FY 1999
FY 2000
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
FY 2008
FY 2009
Total
New Awards
21
35
41
34
35
41
30
38
31
32
40
38
38
35
29
32
550
Continuing
Awards
21
18
26
28
32
20
41
23
23
26
24
28
38
36
26
19
Total Awards
42
53
67
62
67
61
71
61
54
58
64
66
76
71
55
51
979
16
Research Development Seminar Series
• For scholars from diverse populations who are trained &
dedicated for independent research on drug abuse yet
need technical assistance on grant application process
• Provides science and proposal development lectures in
2 training sessions about 6 months apart:
• First focuses on research design, methods, scientific writing,
the peer review process and grant application preparation
• Second centers on mock review led by NIDA SRA
• Small group discussion, and one-on-one mentoring
provided by NIDA staff and extramural experts in the
field of drug abuse and addiction research
• NIDA Program Contact: Flair Lindsey
Research Development Seminar Series
• Must prepare a 1-page concept paper
• Actively participate in proposal development activities
• Expectation is that your application will be submitted
within 6 – 12 months after your last session
Program established in 1986. From
2009 – 2011 NIDA supported 57
early career researchers to attend
the Seminar Series
Examples of NIDA-Supported Research
In Diverse Communities
•
•
•
•
•
•
•
•
Patterns of Substance Abuse
Biological & Behavioral Risk & Protective Factors
Relationship of Stress to Drug Use & Other Disorders
Culturally Appropriate Prevention Interventions
Preventive Interventions with Urban Youth
Culturally Appropriate Substance Abuse
Treatment Strategies
Tobacco Cessation
Treatment Services Research
NIDA Summer Research
Internship Program
• Supports under-represented high school and
undergraduate students in the social sciences and life
sciences
• 8-10 week research placement with NIDA grantees
Summer Research with NIDA
Program Participation - All Years
Gender
Ethnicity
FY
F
M
AA
Hispanic
AI/AN
AAPI
TOTAL
FY 1997
16
6
16
5
1
--
22
FY 1998
FY 1999
FY 2000
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
FY 2008
FY 2009
FY 2010
FY 2011
TOTAL
15
31
25
25
54
48
52
58
63
37
36
45
50
55
610
7
8
7
15
22
24
18
26
14
15
18
17
23
15
235
17
31
19
25
46
43
56
50
49
29
28
33
34
28
504
3
4
6
3
12
11
6
21
17
14
13
5
16
16
152
1
3
3
3
8
5
2
3
2
-3
-3
1
38
1
1
4
9
10
13
6
10
9
9
10
24
14
11
131
22
39
32
40
76
72
70
84
77
52
54
62
73
70
845
NIDA Minority Diversity Programs
• Preparing researchers to better address minority
health disparities
• Stimulating/Encouraging research that will lead to
more effective drug abuse and drug abuse related
prevention and treatment approaches for
racial/ethnic minority populations
• Increasing the number of racial/ethnic minority
researchers engaged in drug abuse and related
research
22
National Institute on Drug Abuse
NIDA Has Made a Commitment in You
• Believe in your research skills and abilities
• Your research has the potential to make an
impact in the substance abuse and health
disparities field
Questions?
National Institute on Minority
Health and Health Disparities
In 2010, NIH announced the transition of the National Center on
Minority Health and Health Disparities (NCMHD) into the
National Institute on Minority Health and Health Disparities
(NIMHD).
This transition gives the institute a more defined role in the NIH's
research agenda against health disparities, which it defines as
differences in the incidence, prevalence, mortality, and burden of
diseases and other adverse health conditions that exist among
specific population groups.
Funding Opportunity Announcements:
NIMHD Basic and Applied Biomedical Research on Minority
Health and Health Disparities (R01) RFA-MD-12-004
NIMHD Social, Behavioral, Health Services, and Policy Research
on Minority Health and Health Disparities (R01)
RFA-MD-12-003
Conferences and Scientific Meetings PA-10-071